Radiant Innovation Inc. designs and develops infrared technology products.
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$40.95|
|52 Week High||NT$40.00|
|52 Week Low||NT$97.80|
|1 Month Change||-16.94%|
|3 Month Change||-42.57%|
|1 Year Change||-56.44%|
|3 Year Change||135.35%|
|5 Year Change||71.34%|
|Change since IPO||266.09%|
Recent News & Updates
|3373||TW Medical Equipment||TW Market|
Return vs Industry: 3373 underperformed the TW Medical Equipment industry which returned 5.4% over the past year.
Return vs Market: 3373 underperformed the TW Market which returned 33.6% over the past year.
Stable Share Price: 3373 is more volatile than 75% of TW stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 3373's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
Radiant Innovation Inc. designs and develops infrared technology products. It offers medical infrared thermometers, industrial use infrared thermometers, and CO2 monitors. The company also provides infrared ear and forehead thermometers, multi-function thermometers, disposable probe covers, and TMS products.
Is Radiant Innovation undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 3373 (NT$40.95) is trading below our estimate of fair value (NT$215.24)
Significantly Below Fair Value: 3373 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 3373 is good value based on its PE Ratio (4.7x) compared to the TW Medical Equipment industry average (22.8x).
PE vs Market: 3373 is good value based on its PE Ratio (4.7x) compared to the TW market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 3373's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 3373 is good value based on its PB Ratio (1.2x) compared to the TW Medical Equipment industry average (2.1x).
How is Radiant Innovation forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Radiant Innovation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Radiant Innovation performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 3373 has a high level of non-cash earnings.
Growing Profit Margin: 3373's current net profit margins (17.6%) are lower than last year (31.1%).
Past Earnings Growth Analysis
Earnings Trend: 3373's earnings have grown significantly by 69.5% per year over the past 5 years.
Accelerating Growth: 3373's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 3373 had negative earnings growth (-22%) over the past year, making it difficult to compare to the Medical Equipment industry average (9.5%).
Return on Equity
High ROE: 3373's Return on Equity (25.1%) is considered high.
How is Radiant Innovation's financial position?
Financial Position Analysis
Short Term Liabilities: 3373's short term assets (NT$1.5B) exceed its short term liabilities (NT$228.0M).
Long Term Liabilities: 3373's short term assets (NT$1.5B) exceed its long term liabilities (NT$7.6M).
Debt to Equity History and Analysis
Debt Level: 3373 is debt free.
Reducing Debt: 3373 had no debt 5 years ago.
Debt Coverage: 3373 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 3373 has no debt, therefore coverage of interest payments is not a concern.
What is Radiant Innovation current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 3373's dividend (24.42%) is higher than the bottom 25% of dividend payers in the TW market (1.94%).
High Dividend: 3373's dividend (24.42%) is in the top 25% of dividend payers in the TW market (5.25%)
Stability and Growth of Payments
Stable Dividend: 3373's dividend payments have been volatile in the past 10 years.
Growing Dividend: 3373's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (115.6%), 3373's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Radiant Innovation has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Radiant Innovation Inc.'s employee growth, exchange listings and data sources
- Name: Radiant Innovation Inc.
- Ticker: 3373
- Exchange: TPEX
- Founded: 2000
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: NT$1.768b
- Shares outstanding: 43.29m
- Website: https://www.radiantek.com.tw
- Radiant Innovation Inc.
- No. 3, Industrial East 9th Road
- 1st Floor
- Hsinchu City
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/17 15:38|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.